Assessing Physician and Patient Acceptance of Infliximab Biosimilars in Rheumatoid Arthritis, Ankylosing Spondyloarthritis and Psoriatic Arthritis Across Germany

Patient Preference and Adherence - New Zealand
doi 10.2147/ppa.s129333

Related search